MEK inhibition significantly decreased tumor growth in all of the MPNST lines, yet substantial response heterogeneity was observed in the NF1-MET and NF1-P53 tumors (Figure 2A–C) [6]. The gene discussed is MET; the disease is malignant peripheral nerve sheath tumor.